Locations:
Search IconSearch

Neurosciences

690×380-Cummings
August 12, 2014/Neurosciences/Research

Can Repurposing a Cancer Agent Open the Door to Disease-Modifying AD Therapy?

BEAT-AD trial gives established therapy a new twist

690×380-Mehra

How Studies of Sleep-Disordered Breathing Are Shedding Light on Atrial Fibrillation

Strong epidemiologic findings are put to the test in ongoing clinical studies

690×380-Bell

When Should We Return Athletes to Play After Cervical Spine Injuries?

Limited data makes it hard to avoid putting necks on the line

gamma-knife_690x380
August 6, 2014/Cancer/Radiation Oncology

Gamma Knife® Now Option for More Brain Metastases

Higher isodose safe and efficient for 6 to 10 lesions

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

690×380.Udayasankar

When Should Fetal MRI Be Used to Guide Clinical Decision-Making?

How and why MRI’s role in fetal neuroimaging has expanded

Retouched_Device-690-x-380
July 31, 2014/Cancer/Research

New Studies Assess Promise of Tumor Treating Fields

Trials examine low-intensity electricity’s effect on recurrent glioblastoma

690×380-Frontera
July 29, 2014/Neurosciences/Research

Early Brain Injury After SAH: Is Ischemia Happening Faster Than We Imagined?

Research sheds light on etiology for early injury after aneurysm rupture

690×380-Pioro-Pseudobulbar
July 24, 2014/Neurosciences/Research

No Laughing Matter: Defining the Role of a New Agent for Pseudobulbar Affect

Exploring new uses of first approved therapy for PBA

BackPage 112 of 113Next

Advertisement

Ad